Date | Name | Shares | Transaction | Value |
Nov 8, 2024
| Pierce H. Norton See Remarks; Director |
90,400
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
8,914,344.00
|
Nov 8, 2024
| James R Hoskin See Remarks |
4,185
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
412,682.85
|
Nov 8, 2024
| Scott D. Schingen See remarks |
56,825
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
5,603,513.25
|
Nov 8, 2024
| Mary M. Spears See Remarks |
23,675
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
2,334,591.75
|
Nov 8, 2024
| Kevin L. Burdick See Remarks |
157,776
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
15,558,291.36
|
Nov 8, 2024
| Walter S. Hulse See Remarks |
154,554
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
15,240,569.94
|
Nov 8, 2024
| Lyndon C. Taylor See Remarks |
21
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
2,070.81
|
Nov 8, 2024
| Sheridan C. Swords See Remarks |
227,449
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
22,428,745.89
|
Nov 8, 2024
| Charles M. Kelley See Remarks |
125,710
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $98.61 per share |
12,396,263.10
|
Jul 3, 2024
| Pierce H. Norton President and CEO; Director |
82,447
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.55 per share |
6,723,552.85
|
Jul 3, 2024
| Pierce H. Norton President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Jul 3, 2024
| Pierce H. Norton President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Jul 3, 2024
| Pierce H. Norton President and CEO; Director |
90,385
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $81.55 per share |
7,370,896.75
|
Jul 3, 2024
| Pierce H. Norton President and CEO; Director |
96,648
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 4, 2024
| Wayne T. Smith Director |
2,700
| Open market or private purchase of non-derivative security Non-derivative transaction at $75.25 per share |
203,175.00
|
Feb 22, 2024
| Scott D. Schingen Senior VP Natural Gas Liquids |
54,620
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $71.99 per share |
3,932,093.80
|
Feb 22, 2024
| Scott D. Schingen Senior VP Natural Gas Liquids |
N/A
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Feb 22, 2024
| Scott D. Schingen Senior VP Natural Gas Liquids |
N/A
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Feb 12, 2024
| Lori A. Gobillot Director |
2,504
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|